Exelixis, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US30161Q1040
USD
41.29
-1.08 (-2.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,320.13
2,168.70
1,830.21
1,611.06
1,434.97
987.54
967.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,320.13
2,168.70
1,830.21
1,611.06
1,434.97
987.54
967.77
Raw Material Cost
83.70
76.22
72.55
57.91
52.87
36.27
33.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
518.73
492.13
542.71
459.86
401.71
293.36
228.24
Other Expenses
82.50
91.04
104.41
89.18
69.37
54.79
33.70
Total Expenditure (Excl Depreciation)
1,427.43
1,478.75
1,659.32
1,409.58
1,148.30
877.48
598.30
Operating Profit (PBDIT) excl Other Income
892.6999999999999
689.9
170.9
201.5
286.70000000000005
110.1
369.5
Other Income
69.02
77.02
86.64
31.67
6.69
20.78
28.64
Operating Profit (PBDIT)
990.77
795.77
283.24
254.03
306.98
144.81
409.28
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-20.51
-85.33
0.00
1.20
0.80
0.00
0.00
Gross Profit (PBDT)
2,236.43
2,092.49
1,757.66
1,553.15
1,382.10
951.27
934.68
Depreciation
29.05
28.80
25.72
20.88
13.63
13.97
11.17
Profit Before Tax
941.21
681.64
257.52
234.35
294.15
130.84
398.11
Tax
158.64
160.37
49.76
52.07
63.09
19.06
77.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
782.57
521.27
207.76
182.28
231.06
111.78
321.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
782.57
521.27
207.76
182.28
231.06
111.78
321.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
782.57
521.27
207.76
182.28
231.06
111.78
321.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,161.32
2,244.20
2,263.91
2,488.43
2,210.61
1,879.11
1,685.97
Earnings per share (EPS)
2.78
1.76
0.65
0.56
0.72
0.35
1.02
Diluted Earnings per share
2.78
1.76
0.65
0.56
0.72
0.35
1.02
Operating Profit Margin (Excl OI)
38.48%
31.81%
9.34%
12.51%
19.98%
11.14%
38.18%
Gross Profit Margin
41.82%
32.76%
15.48%
15.84%
21.45%
14.66%
42.29%
PAT Margin
33.73%
24.04%
11.35%
11.31%
16.1%
11.32%
33.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 6.98% vs 18.50% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 50.12% vs 150.87% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 28.24% vs 265.62% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Exelixis, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,320.13
4,381.00
-2,060.87
-47.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,320.13
4,381.00
-2,060.87
-47.04%
Raw Material Cost
83.70
3,428.00
-3,344.30
-97.56%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
254.00
-254.00
-100.00%
Selling and Distribution Expenses
518.73
779.00
-260.27
-33.41%
Other Expenses
82.50
-23.70
106.20
448.10%
Total Expenditure (Excl Depreciation)
1,427.43
4,224.00
-2,796.57
-66.21%
Operating Profit (PBDIT) excl Other Income
892.70
157.00
735.70
468.60%
Other Income
69.02
-24.00
93.02
387.58%
Operating Profit (PBDIT)
990.77
610.00
380.77
62.42%
Interest
0.00
254.00
-254.00
-100.00%
Exceptional Items
-20.51
-894.00
873.49
97.71%
Gross Profit (PBDT)
2,236.43
953.00
1,283.43
134.67%
Depreciation
29.05
489.00
-459.95
-94.06%
Profit Before Tax
941.21
-1,027.00
1,968.21
191.65%
Tax
158.64
16.00
142.64
891.50%
Provisions and contingencies
0
0
0.00
Profit After Tax
782.57
-1,043.00
1,825.57
175.03%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
782.57
-1,043.00
1,825.57
175.03%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
782.57
-1,043.00
1,825.57
175.03%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
2,161.32
3,604.00
-1,442.68
-40.03%
Earnings per share (EPS)
2.78
-5.76
8.54
148.26%
Diluted Earnings per share
2.78
-5.76
8.54
148.26%
Operating Profit Margin (Excl OI)
38.48%
3.31%
0.00
35.17%
Gross Profit Margin
41.82%
-12.28%
0.00
54.10%
PAT Margin
33.73%
-23.81%
0.00
57.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 232.01 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 6.98% vs 18.50% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 78.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 50.12% vs 150.87% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 92.18 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 28.24% vs 265.62% in Dec 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.48%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024